Cannabisbaseret smertebehandling kan stadigvæk ikke anbefales

Press/Media: Press / Media

Description

I en artikel i Dagens Medicin skriver Helge Kasch fra Aarhus Universitetshospital og Bo Biering-Sørensen fra Rigshospitalet og Københavns Universitetshospital, samt Salome Kristensen, Lene Wohlfahrt Dreyer, Kristian Kjær-Staal Petersen og Lars Arendt-Nielsen fra Aalborg Universitetshospital, at cannabisbaseret medicin stadig ikke kan godkendes til smertebehandling. Forfatterne reagerer på artiklen "Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain - A retrospective observational real-world study" fra European Journal of Pain, som viser, at medicinsk cannabisbehandling er samfundsøkonomisk sikkert, ansvarligt og effektivt. Forfatterne er uenige. (Resumé leveret af Infomedia) Kilder: Dagens Medicin, sektion 1, side 23, 17-03-2023

Period	17 Mar 2023

Media contributions

Title	Cannabisbaseret smertebehandling kan stadigvæk ikke anbefales
Media name/outlet	Dagens Medicin
Date	17/03/2023
Producer/Author	Helge Kasch, dr. med., ph.d., klinisk lektor, Aarhus Universitetshospital
URL	Login to display link to press clippings from Infomedia
Persons	Kristian Kjær-Staal Petersen, Lars Arendt-Nielsen, Lene Wohlfahrt Dreyer, Salome Kristensen

View all 1

View less

Cannabisbaseret smertebehandling kan stadigvæk ikke anbefales

Description

Media contributions

Related content

Publications

Safety and Effectiveness of Cannabinoids to Danish Patients with Treatment Refractory Chronic Pain - A Retrospective Observational Real-world Study

Methodology considerations for "Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain" by Horsted et al